Clicking a link below will scroll the
page down to the relevant section
- A Phase I Study of Weekly Low-Dose Cisplatin Plus Escalating Doses of Oral RAD001 (Everolimus) for Patients with Advanced Solid Tumors
Fury, Matthew, MD, PhD
[Protocol 06-129]
- A Phase II Study of AZD0530 for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Pfister, David, MD
[Protocol 06-074]
- A Phase II Study of Concurrent Chemoradiotherapy Using Three-Dimensional Conformal Radiotherapy or Intensity-Modulated Radiation Therapy Plus Bevacizumab for Locally or Regionally Advanced Nasopharyngeal Cancer
Lee, Nancy, MD
[Protocol 07-030]
- A Phase II Study of Pemetrexed and Gemcitabine for Metastatic/Recurrent Head and Neck Cancer
Pfister, David, MD
[Protocol 06-087]
- A Phase II Study of Radiotherapy (IMRT) and Cisplatin Plus Bevacizumab for Patients with Locally Advanced Head and Neck Cancer
Pfister, David, MD
[Protocol 06-130]
- Development and Validation of a New Patient-Reported Outcome Instrument on the Impact of Altered Facial Appearance Following Oncologic Head and Neck Resection and Reconstruction
Pusic, Andrea, MD, MHS
[Protocol 07-098]
- Feasibility Study Using Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Head and Neck Cancer Patients
Lee, Nancy, MD
[Protocol 04-070]
- Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging to Assess Tongue Function after Treatment for Tongue Cancer
Kraus, Dennis, MD
[Protocol 02-093]
- Functional Voice and Speech Outcomes Following Surgical Voice Restorations: A Comparison of Pharyngeal Reconstruction Approaches
Kraus, Dennis, MD
[Protocol 05-104]
- Improving Functional Outcomes in Patients with Unilateral Vocal Cord Paralysis: Assessment of Adaptation Using Functional Magnetic Resonance Imaging
Kraus, Dennis, MD
[Protocol 05-036]
- Microvascular Reconstruction for Advanced-Stage Head and Neck Cancer Patients: A Prospective Analysis of Quality of Life and Symptom Relief
Pusic, Andrea, MD, MHS
[Protocol 07-150]
- Pilot Study of Sulindac, a Pan-COX Inhibitor, in Oral Premalignant Lesions
Boyle, Jay, MD
[Protocol 04-099]
- Prospective Evaluation of Quality of Life and Development of Measures in Patients with Cancer of the Oral Cavity
Kissane, David, MD
[Protocol 04-137]
- Tongue Strength and Swallowing in Oral Cancer
Branski, Ryan, PhD
[Protocol 06-104]
|
